The management of urologic cancers has transformed over the years with technical innovations in surgery and radiation, advancements in targeted therapy, hormonal therapy, chemotherapy and immunotherapy. The team aims to deliver state-of-the-art disease management by integrating the latest medical technologies, minimally invasive therapies and research.
The diseases treated include malignancies of Prostate, adrenal, kidney, upper urinary tracts, Urinary bladder, Testis, Penile and urethral cancers. In early-stage cancer different surgical modalities are employed to treat these cancers, often in a multi-disciplinary team approach with the integration of expertise by medical oncology and/or radiation oncology.
In advanced/metastatic stage urological cancers, systemic therapy approach comprising chemotherapy, hormonal therapy, targeted therapy and immunotherapy, alone or in combinations is employed to achieve maximum patient benefit.